U.S. flag

An official website of the United States government

NM_001161352.2(KCNMA1):c.1315G>A (p.Glu439Lys) AND Generalized epilepsy-paroxysmal dyskinesia syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 14, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002839272.2

Allele description

NM_001161352.2(KCNMA1):c.1315G>A (p.Glu439Lys)

Gene:
KCNMA1:potassium calcium-activated channel subfamily M alpha 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q22.3
Genomic location:
Preferred name:
NM_001161352.2(KCNMA1):c.1315G>A (p.Glu439Lys)
HGVS:
  • NC_000010.11:g.77090419C>T
  • NG_012270.1:g.552401G>A
  • NM_001014797.3:c.1315G>A
  • NM_001161352.2:c.1315G>AMANE SELECT
  • NM_001161353.2:c.1315G>A
  • NM_001271518.2:c.1153G>A
  • NM_001271519.2:c.1315G>A
  • NM_001322829.2:c.1315G>A
  • NM_001322830.2:c.1315G>A
  • NM_001322832.2:c.1315G>A
  • NM_001322835.2:c.1315G>A
  • NM_001322836.2:c.1315G>A
  • NM_001322837.2:c.1315G>A
  • NM_001322838.2:c.775G>A
  • NM_001410940.1:c.1315G>A
  • NM_002247.4:c.1315G>A
  • NP_001014797.1:p.Glu439Lys
  • NP_001154824.1:p.Glu439Lys
  • NP_001154825.1:p.Glu439Lys
  • NP_001258447.1:p.Glu385Lys
  • NP_001258448.1:p.Glu439Lys
  • NP_001309758.1:p.Glu439Lys
  • NP_001309759.1:p.Glu439Lys
  • NP_001309761.1:p.Glu439Lys
  • NP_001309764.1:p.Glu439Lys
  • NP_001309765.1:p.Glu439Lys
  • NP_001309766.1:p.Glu439Lys
  • NP_001309767.1:p.Glu259Lys
  • NP_001397869.1:p.Glu439Lys
  • NP_002238.2:p.Glu439Lys
  • NC_000010.10:g.78850177C>T
Protein change:
E259K
Molecular consequence:
  • NM_001014797.3:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001161352.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001161353.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001271518.2:c.1153G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001271519.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322829.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322830.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322832.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322835.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322836.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322837.2:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322838.2:c.775G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001410940.1:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002247.4:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Generalized epilepsy-paroxysmal dyskinesia syndrome (PNKD3)
Synonyms:
Generalized epilepsy and paroxysmal dyskinesia; Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy
Identifiers:
MONDO: MONDO:0012276; MedGen: C5574945; Orphanet: 79137; OMIM: 609446

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003212688Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Nov 14, 2022) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV003212688.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNMA1 protein function. This variant has not been reported in the literature in individuals affected with KCNMA1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 439 of the KCNMA1 protein (p.Glu439Lys).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024